Online Mendelian Inheritance in Man (OMIM) (original) (raw)

  1. Aguirre, A., Donnadieu, M., Job, J.-C.High-affinity serum growth-hormone-binding protein, absent in Laron-type dwarfism, is diminished in heterozygous parents. Horm. Res. 34: 4-8, 1990. [PubMed: 2074091] [Full Text: https://doi.org/10.1159/000181786\]
  2. Amselem, S., Duquesnoy, P., Attree, O., Novelli, G., Bousnina, S., Postel-Vinay, M.-C., Goossens, M.Laron dwarfism and mutations of the growth hormone receptor gene. New Eng. J. Med. 321: 989-995, 1989. [PubMed: 2779634] [Full Text: https://doi.org/10.1056/NEJM198910123211501\]
  3. Arden, K. C., Boutin, J.-M., Djiane, J., Kelly, P. A., Cavenee, W. K.The receptors for prolactin and growth hormone are localized in the same region of human chromosome 5. Cytogenet. Cell Genet. 53: 161-165, 1990. [PubMed: 2369845] [Full Text: https://doi.org/10.1159/000132919\]
  4. Arden, K. C., Cavenee, W. K., Boutin, J.-M., Kelly, P. A.The genes encoding the receptors for prolactin and growth hormone map to human chromosome 5. (Abstract) Am. J. Hum. Genet. 45 (suppl.): A129 only, 1989.
  5. Ayling, R. M., Ross, R, Towner, P., Von Laue, S., Finidori, J., Moutoussamy, S., Buchanan, C. R., Clayton, P. E., Norman, M. R.A dominant-negative mutation of the growth hormone receptor causes familial short stature. Nature Genet. 16: 13-14, 1997. [PubMed: 9140387] [Full Text: https://doi.org/10.1038/ng0597-13\]
  6. Backeljauw, P. F., Underwood, L. E., the GHIS Collaborative Group.Prolonged treatment with recombinant insulin-like growth factor-I in children with growth hormone insensitivity syndrome--a clinical research center study. J. Clin. Endocr. Metab. 81: 3312-3317, 1996. [PubMed: 8784089] [Full Text: https://doi.org/10.1210/jcem.81.9.8784089\]
  7. Backeljauw, P. F., Underwood, L. E., The GHIS Collaborative Group.Therapy for 6.5-7.5 years with recombinant insulin-like growth factor I in children with growth hormone insensitivity syndrome: a clinical research center study. J. Clin. Endocr. Metab. 86: 1504-1510, 2001. [PubMed: 11297575] [Full Text: https://doi.org/10.1210/jcem.86.4.7381\]
  8. Barton, D. E., Foellmer, B. E., Wood, W. I., Francke, U.Chromosome mapping of the growth hormone receptor gene in man and mouse. Cytogenet. Cell Genet. 50: 137-141, 1989. [PubMed: 2776481] [Full Text: https://doi.org/10.1159/000132743\]
  9. Baumbach, L., Schiavi, A., Bartlett, R., Perera, E., Day, J., Brown, M. R., Stein, S., Eidson, M., Parks, J. S., Cleveland, W.Clinical, biochemical, and molecular investigations of a genetic isolate of growth hormone insensitivity (Laron's Syndrome). J. Clin. Endocr. Metab. 82: 444-451, 1997. [PubMed: 9024234] [Full Text: https://doi.org/10.1210/jcem.82.2.3784\]
  10. Behncken, S. N., Rowlinson, S. W., Rowland, J. E., Conway-Campbell, B. L., Monks, T. A., Waters, M. J.Aspartate 171 is the major primate-specific determinant of human growth hormone. J. Biol. Chem. 272: 27077-27083, 1997. [PubMed: 9341147] [Full Text: https://doi.org/10.1074/jbc.272.43.27077\]
  11. Benbassat, C. A., Eshed, V., Kamjin, M., Laron, Z.Are adult patients with Laron syndrome osteopenic? A comparison between dual-energy x-ray absorptiometry and volumetric bone densities. J. Clin. Endocr. Metab. 88: 4586-4589, 2003. [PubMed: 14557426] [Full Text: https://doi.org/10.1210/jc.2003-030623\]
  12. Berg, M. A., Argente, J., Chernausek, S., Gracia, R., Guevara-Aguirre, J., Hopp, M., Perez-Jurado, L., Rosenbloom, A., Toledo, S. P. A., Francke, U.Diverse growth hormone receptor gene mutations in Laron syndrome. Am. J. Hum. Genet. 52: 998-1005, 1993. [PubMed: 8488849]
  13. Buchanan, C. R., Maheshwari, H. G., Norman, M. R., Morrell, D. J., Preece, M. A.Laron-type dwarfism with apparently normal high affinity serum growth hormone-binding protein. Clin. Endocr. 35: 179-185, 1991. [PubMed: 1934534] [Full Text: https://doi.org/10.1111/j.1365-2265.1991.tb03518.x\]
  14. Cogan, J. D., Phillips, J. A., III.Inherited defects in growth hormone synthesis and action.In: Scriver, C. R.; Beaudet, A. L.; Sly, W. S.; Valle, D. : The Metabolic and Molecular Bases of Inherited Disease. Vol. II. (8th ed.) New York: McGraw-Hill (pub.) 2001.
  15. Daughaday, W. H., Laron, Z., Pertzelan, A., Heins, J. N.Defective sulfation factor generation: a possible etiological link in dwarfism. Trans. Assoc. Am. Phys. 82: 129-140, 1969. [PubMed: 5375147]
  16. Daughaday, W. H., Trivedi, B.Absence of serum growth hormone binding protein in patients with growth hormone receptor deficiency (Laron dwarfism). Proc. Nat. Acad. Sci. 84: 4636-4640, 1987. [PubMed: 3474620] [Full Text: https://doi.org/10.1073/pnas.84.13.4636\]
  17. Daughaday, W. H., Trivedi, B.Absence of serum growth hormone binding protein of Laron dwarfs links the binding protein with the cellular growth hormone receptor. (Abstract) Clin. Res. 35: 646A only, 1987.
  18. Eicher, E. M., Lee, B. K.Growth hormone receptor (Ghr) and hemoglobin alpha-chain pseudogene 3 (Hba-ps3) map proximal to the myelocytomatosis oncogene (Myc) on mouse chromosome 15. Mammalian Genome 1: 57-58, 1991. [PubMed: 1794046] [Full Text: https://doi.org/10.1007/BF00350847\]
  19. Eshet, R., Laron, Z., Pertzelan, A., Arnon, R., Dintzman, M.Defect of human growth hormone receptors in the liver of two patients with Laron-type dwarfism. Isr. J. Med. Sci. 20: 8-11, 1984. [PubMed: 6321400]
  20. Francke, U., Berg, M. A.Genetic heterogeneity in Laron syndrome. Acta Paediat. Scand. 391 (suppl.): 3-7, 1993.
  21. Geffner, M. E., Golde, D. W., Lippe, B. M., Kaplan, S. A., Bersch, N., Li, C. H.Tissues of the Laron dwarf are sensitive to insulin-like growth factor I but not to growth hormone. J. Clin. Endocr. Metab. 64: 1042-1046, 1987. [PubMed: 3031118] [Full Text: https://doi.org/10.1210/jcem-64-5-1042\]
  22. Goddard, A. D., Covello, R., Luoh, S.-M., Clackson, T., Attie, K. M., Gesundheit, N., Rundle, A. C., Wells, J. A., Carlsson, L. M. S.Mutations of the growth hormone receptor in children with idiopathic short stature. New Eng. J. Med. 333: 1093-1098, 1995. [PubMed: 7565946] [Full Text: https://doi.org/10.1056/NEJM199510263331701\]
  23. Golde, D. W., Bersch, N., Kaplan, S. A., Rimoin, D. L., Li, C. H.Peripheral unresponsiveness to human growth hormone in Laron dwarfism. New Eng. J. Med. 303: 1156-1159, 1980. [PubMed: 6106895] [Full Text: https://doi.org/10.1056/NEJM198011133032006\]
  24. Guevara-Aguirre, J., Balasubramanian, P., Guevara-Aguirre, M., Wei, M., Madia, F., Cheng, C.-W., Hwang, D., Martin-Montalvo, A., Saavedra, J., Ingles, S., de Cabo, R., Cohen, P., Longo, V. D.Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans. Sci. Transl. Med. 3: 70ra13, 2011. Note: Electronic Article. [PubMed: 21325617] [Full Text: https://doi.org/10.1126/scitranslmed.3001845\]
  25. Guevara-Aguirre, J., Rosenbloom, A. L., Vaccarello, M. A., Fielder, P. J., de la Vega, A., Diamond, F. B., Jr., Rosenfeld, R. G.Growth hormone receptor deficiency (Laron syndrome): clinical and genetic characteristics. Acta Paediat. Scand. 377 (suppl.): 96-103, 1991.
  26. Guevara-Aguirre, J., Rosenbloom, A. L., Vasconez, O., Martinez, V., Gargosky, S. E., Allen, L., Rosenfeld, R. G.Two-year treatment of growth hormone (GH) receptor deficiency with recombinant insulin-like growth factor I in 22 children: comparison of two dosage levels and to GH-treated GH deficiency. J. Clin. Endocr. Metab. 82: 629-633, 1997. [PubMed: 9024266] [Full Text: https://doi.org/10.1210/jcem.82.2.3743\]
  27. Hopwood, N. J., Hintz, R. L., Gertner, J. M., Attie, K. M., Johanson, A. J., Baptista, J., Kuntze, J., Blizzard, R. M., Cara, J. F., Chernausek, S. D., Kaplan, S. L., Lippe, B. M., Plotnick, L. P., Saenger, P.Growth response of children with non-growth-hormone deficiency and marked short stature during three years of growth hormone therapy. J. Pediat. 123: 215-222, 1993. [PubMed: 8345416] [Full Text: https://doi.org/10.1016/s0022-3476(05)81691-9\]
  28. Jacobs, L. S., Sneid, D. S., Garland, J. T., Laron, Z., Daughaday, W. H.Receptor-active growth hormone in Laron dwarfism. J. Clin. Endocr. 42: 403-406, 1976. [PubMed: 177445] [Full Text: https://doi.org/10.1210/jcem-42-2-403\]
  29. Kastrup, K. W., Andersen, H., Hanssen, K. F.Increased immunoreactive plasma and urinary growth hormone in growth retardation with defective generation of somatomedin A (Laron's syndrome). Acta Paediat. Scand. 64: 613-618, 1975. [PubMed: 1155081] [Full Text: https://doi.org/10.1111/j.1651-2227.1975.tb03891.x\]
  30. Keret, R., Pertzelan, A., Zeharia, A., Zadik, Z., Laron, Z.Growth hormone (hGH) secretion and turnover in three patients with Laron-type dwarfism. Isr. J. Med. Sci. 24: 75-79, 1988. [PubMed: 3356536]
  31. Laron, Z., Anin, S., Klipper-Aurbach, Y., Klinger, B.Effects of insulin-like growth factor on linear growth, head circumference, and body fat in patients with Laron-type dwarfism. Lancet 339: 1258-1261, 1992. [PubMed: 1349669] [Full Text: https://doi.org/10.1016/0140-6736(92)91594-x\]
  32. Laron, Z., Klinger, B., Erster, B., Anin, S.Effect of acute administration of insulin-like growth factor in patients with Laron-type dwarfism. Lancet 332: 1170-1172, 1988. Note: Originally Volume II. [PubMed: 2903379] [Full Text: https://doi.org/10.1016/s0140-6736(88)90236-x\]
  33. Laron, Z., Pertzelan, A., Mannheimer, S.Genetic pituitary dwarfism with high serum concentration of growth hormone: a new inborn error of metabolism? Isr. J. Med. Sci. 2: 152-155, 1966. [PubMed: 5916640]
  34. Laron, Z., Sarel, R., Pertzelan, A.Puberty in Laron type dwarfism. Europ. J. Pediat. 134: 79-83, 1980. [PubMed: 7408914] [Full Text: https://doi.org/10.1007/BF00442408\]
  35. Laron, Z., Silbergeld, A.A child with phenotypic Laron dwarfism and normal somatomedin levels. (Letter) New Eng. J. Med. 320: 1698 only, 1989. [PubMed: 2725626] [Full Text: https://doi.org/10.1056/NEJM198906223202516\]
  36. Laron, Z.Syndrome of familial dwarfism and high plasma immunoreactive growth hormone. Isr. J. Med. Sci. 10: 1247-1254, 1974. [PubMed: 4436030]
  37. Laron, Z.The syndrome of familial dwarfism and high plasma immunoreactive human growth hormone. Birth Defects Orig. Art. Ser. X(4): 231-238, 1974.
  38. Laron, Z.Hereditary dwarfism with high GH levels. Curr. Contents 33: 24-25, 1990.
  39. Laron, Z.Laron syndrome (primary growth hormone resistance or insensitivity): the personal experience 1958-2003. J. Clin. Endocr. Metab. 89: 1031-1044, 2004. [PubMed: 15001582] [Full Text: https://doi.org/10.1210/jc.2003-031033\]
  40. Mauras, N., Martinez, V., Rini, A., Guevara-Aguirre, J.Recombinant human insulin-like growth factor I has significant anabolic effects in adults with growth hormone receptor deficiency: studies on protein, glucose, and lipid metabolism. J. Clin. Endocr. Metab. 85: 3036-3042, 2000. [PubMed: 10999782] [Full Text: https://doi.org/10.1210/jcem.85.9.6772\]
  41. Merimee, T. J., Hall, J., Rabinowitz, D., McKusick, V. A., Rimoin, D. L.An unusual variety of endocrine dwarfism: subresponsiveness to growth hormone in a sexually mature dwarf. Lancet 292: 191-193, 1968. Note: Originally Volume II. [PubMed: 4173406] [Full Text: https://doi.org/10.1016/s0140-6736(68)92623-8\]
  42. Najjar, S. S., Khachadurian, A. K., Ilbawi, M. N., Blizzard, R. M.Dwarfism with elevated levels of plasma growth hormone. New Eng. J. Med. 284: 809-812, 1971. [PubMed: 5549802] [Full Text: https://doi.org/10.1056/NEJM197104152841502\]
  43. Pertzelan, A., Adam, A., Laron, Z.Genetic aspects of pituitary dwarfism due to absence or biological inactivity of growth hormone. Isr. J. Med. Sci. 4: 895-900, 1968. [PubMed: 5707789]
  44. Phillips, J. A., III.Molecular biology of growth hormone receptor dysfunction. Acta Paediatr. Suppl. 383: 127-131, 1992. [PubMed: 1458007]
  45. Phillips, L. S., Vassilopoulou-Sellin, R.Somatomedins. New Eng. J. Med. 302: 371-380, 1980. [PubMed: 6243390] [Full Text: https://doi.org/10.1056/NEJM198002143020704\]
  46. Pierson, M., Malaprade, D., Fortier, G., Belleville, F., Lasbennes, A., Wuilbercq, L.Le nanisme familial de type Laron: deficit genetique premaire en somatomedine. Arch. Franc. Pediat. 35: 151-164, 1978. [PubMed: 637670]
  47. Pintor, C., Loche, S., Cella, S. G., Muller, E. E., Baumann, G.A child with phenotypic Laron dwarfism and normal somatomedin levels. New Eng. J. Med. 320: 376-379, 1989. [PubMed: 2913494] [Full Text: https://doi.org/10.1056/NEJM198902093200607\]
  48. Pintor, C., Loche, S., Cella, S. G., Muller, E. E., Baumann, G.Correction and withdrawal of conclusion: a child with phenotypic Laron dwarfism and normal somatomedin levels. (Letter) New Eng. J. Med. 323: 1485 only, 1990. [PubMed: 2288600]
  49. Rosenbloom, A. L., Guevara-Aguirre, J., Rosenfeld, R. G., Fiedler, P. J.The little women of Loja-- growth hormone-receptor deficiency in an inbred population of southern Ecuador. New Eng. J. Med. 323: 1367-1374, 1990. [PubMed: 2233903] [Full Text: https://doi.org/10.1056/NEJM199011153232002\]
  50. Rosenbloom, A. L., Guevara-Aguirre, J., Rosenfeld, R. G., Francke, U.Growth hormone receptor deficiency in Ecuador. J. Clin. Endocr. Metab. 84: 4436-4443, 1999. [PubMed: 10599699] [Full Text: https://doi.org/10.1210/jcem.84.12.6283\]
  51. Saldanha, P. H., Toledo, S. P. A.Familial dwarfism with high IR-GH: report of two affected sibs with genetic and epidemiologic considerations. Hum. Genet. 59: 367-372, 1981. [PubMed: 7333592] [Full Text: https://doi.org/10.1007/BF00295474\]
  52. Schaefer, G. B., Rosenbloom, A. L., Guevara-Aguirre, J., Campbell, E. A., Ullrich, F., Patil, K., Frias, J. L.Facial morphometry of Ecuadorian patients with growth hormone receptor deficiency/Laron syndrome. J. Med. Genet. 31: 635-639, 1994. [PubMed: 7815422] [Full Text: https://doi.org/10.1136/jmg.31.8.635\]
  53. Souza, S. C., Frick, G. P., Wang, X., Kopchick, J. J., Lobo, R. B., Goodman, H. M.A single arginine residue determines species specificity of the human growth hormone receptor. Proc. Nat. Acad. Sci. 92: 959-963, 1995. [PubMed: 7862673] [Full Text: https://doi.org/10.1073/pnas.92.4.959\]
  54. Walker, J. L., Ginalska-Malinowska, M., Romer, T. E., Pucilowska, J. B., Underwood, L. E.Effects of the infusion of insulin-like growth factor I in a child with growth hormone insensitivity syndrome (Laron dwarfism). New Eng. J. Med. 324: 1483-1488, 1991. [PubMed: 2023608] [Full Text: https://doi.org/10.1056/NEJM199105233242107\]
  55. Woods, K. A., Dastot, F., Preece, M. A., Clark, A. J. L., Postel-Vinay, M.-C., Chatelain, P. G., Ranke, M. B., Rosenfeld, R. G., Amselem, S., Savage, M. O.Phenotype:genotype relationships in growth hormone insensitivity syndrome. J. Clin. Endocr. Metab. 82: 3529-3535, 1997. [PubMed: 9360502] [Full Text: https://doi.org/10.1210/jcem.82.11.4389\]
  56. Woods, K. A., Fraser, N. C., Postel-Vinay, M.-C., Savage, M. O., Clark, A. J. L.A homozygous splice site mutation affecting the intracellular domain of the growth hormone (GH) receptor resulting in Laron syndrome with elevated GH-binding protein. J. Clin. Endocr. Metab. 81: 1686-1690, 1996. [PubMed: 8626815] [Full Text: https://doi.org/10.1210/jcem.81.5.8626815\]
  57. Zhou, Y., Xu, B. C., Maheshwari, H. G., He, L., Reed, M., Lozykowski, M., Okada, S., Cataldo, L., Coschigamo, K., Wagner, T. E., Baumann, G., Kopchick, J. J.A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). Proc. Nat. Acad. Sci. 94: 13215-13220, 1997. [PubMed: 9371826] [Full Text: https://doi.org/10.1073/pnas.94.24.13215\]